What is BioSig Technologies, Inc.'s royalty rate?

BioSig Technologies, Inc. (STEX) reported royalty rate of 1% in Q2 2025.

What does royalty rate mean?

The percentage of revenue or gross profit paid to third parties for the use of intellectual property, technology, or commodity rights. It serves as a key indicator of the cost structure associated with proprietary assets and licensing agreements.

BioSig Technologies, Inc. STEX Royalty Rate

Royalty Rate at other companies

Ondas, Inc. ONDS

3%0.0pp

Ondas, Inc. ONDS

$85.5K+23.5%

OS TherapiesOSTX

150%—

Falcon's Beyond GlobalFBYD

$25K0.0%

Flanigan's EnterprisesBDL

1%0.0pp

OS TherapiesOSTX

6%0.0pp

Other financials

Income statement

See full

Revenue$13.0K+8.3%

Gross profit$12.0K-88.9%

Operating income-$35.7M-1,098%

Net income-$46.7M-1,560%

EPS (diluted)-$0.27-92.9%

Balance sheet

See full

Cash & equivalents$6.9M+84.0%

Total debt$15.0K-94.7%

Total equity$159.0M+6,003%

Total assets$173.3M+3,823%

Cash flow

See full

Operating cash flow-$10.2M-813%

CapEx$4.0K-93.1%

Free cash flow-$2.9M+29.4%

Valuation

See full

Market cap$88.66M-56.4%

P/S2,216.6×-5,967×

Profitability

See full

Gross margin80.1%+25.2pp

Operating margin-32,155%-14,261pp

Net margin-25,825%-11,789pp

FCF margin-97,216.7%-106,293pp

Returns & leverage

See full

Return on equity-627.1%—

Debt / equity0×—

Current ratio13.9×+11.5×

Where this comes from

Reported directly by BioSig Technologies, Inc. in its filing.

Tagged under the XBRL concept STEX:RoyaltyRate.

The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioSig Technologies, Inc.'s royalty rate.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioSig Technologies, Inc.'s royalty rate?: BioSig Technologies, Inc. (STEX) reported royalty rate of 1% in Q2 2025.
What does royalty rate mean?: The percentage of revenue or gross profit paid to third parties for the use of intellectual property, technology, or commodity rights. It serves as a key indicator of the cost structure associated with proprietary assets and licensing agreements.